The price-to-earnings ratio for Hologic, Inc. (NASDAQ: HOLX) is 27.35x, which is above its average ratio. Moreover, the 36-month beta value for HOLX is 0.98. Analysts have varying opinions on the stock, with 7 analysts rating it as a “buy,” 7 as “overweight,” 5 as “hold,” and 0 as “sell.”
The public float for HOLX is 229.26M and currently, short sellers hold a 2.25% of that float. On September 11, 2024, HOLX’s average trading volume was 1.54M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
HOLX) stock’s latest price update
Hologic, Inc. (NASDAQ: HOLX)’s stock price has gone decline by -2.22 in comparison to its previous close of 81.96, however, the company has experienced a -1.81% decrease in its stock price over the last five trading days. zacks.com reported 2024-09-11 that Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
HOLX’s Market Performance
Hologic, Inc. (HOLX) has experienced a -1.81% fall in stock performance for the past week, with a -1.99% drop in the past month, and a 9.93% rise in the past quarter. The volatility ratio for the week is 1.83%, and the volatility levels for the past 30 days are at 1.42% for HOLX. The simple moving average for the past 20 days is -1.06% for HOLX’s stock, with a 6.29% simple moving average for the past 200 days.
Analysts’ Opinion of HOLX
Many brokerage firms have already submitted their reports for HOLX stocks, with Stephens repeating the rating for HOLX by listing it as a “Overweight.” The predicted price for HOLX in the upcoming period, according to Stephens is $87 based on the research report published on June 27, 2024 of the current year 2024.
Citigroup, on the other hand, stated in their research note that they expect to see HOLX reach a price target of $95, previously predicting the price at $80. The rating they have provided for HOLX stocks is “Buy” according to the report published on April 03rd, 2024.
Needham gave a rating of “Buy” to HOLX, setting the target price at $95 in the report published on July 14th of the previous year.
HOLX Trading at 0.62% from the 50-Day Moving Average
After a stumble in the market that brought HOLX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -5.35% of loss for the given period.
Volatility was left at 1.42%, however, over the last 30 days, the volatility rate increased by 1.83%, as shares sank -1.65% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +8.24% upper at present.
During the last 5 trading sessions, HOLX fell by -1.73%, which changed the moving average for the period of 200-days by +11.12% in comparison to the 20-day moving average, which settled at $80.93. In addition, Hologic, Inc. saw 12.16% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at HOLX starting from Oberton Karleen Marie, who sale 52,679 shares at the price of $80.56 back on Aug 29 ’24. After this action, Oberton Karleen Marie now owns 84,042 shares of Hologic, Inc., valued at $4,243,662 using the latest closing price.
Oberton Karleen Marie, the Officer of Hologic, Inc., proposed sale 52,679 shares at $80.56 during a trade that took place back on Aug 29 ’24, which means that Oberton Karleen Marie is holding shares at $4,243,657 based on the most recent closing price.
Stock Fundamentals for HOLX
Current profitability levels for the company are sitting at:
- 0.21 for the present operating margin
- 0.55 for the gross margin
The net margin for Hologic, Inc. stands at 0.18. The total capital return value is set at 0.11. Equity return is now at value 13.85, with 7.70 for asset returns.
Based on Hologic, Inc. (HOLX), the company’s capital structure generated 0.34 points at debt to capital in total, while cash flow to debt ratio is standing at 0.46. The debt to equity ratio resting at 0.51. The interest coverage ratio of the stock is 7.08.
Currently, EBITDA for the company is 1.2 billion with net debt to EBITDA at 0.1. When we switch over and look at the enterprise to sales, we see a ratio of 4.71. The receivables turnover for the company is 6.34for trailing twelve months and the total asset turnover is 0.45. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.99.
Conclusion
To wrap up, the performance of Hologic, Inc. (HOLX) has been mixed in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
